User profiles for "author:H. Tsuda"

Hiroko Tsuda

Sleep apnea Center, kyushu university hospital
Verified email at dent.kyushu-u.ac.jp
Cited by 1028

100 years of Drosophila research and its impact on vertebrate neuroscience: a history lesson for the future

HJ Bellen, C Tong, H Tsuda - Nature Reviews Neuroscience, 2010 - nature.com
Discoveries in fruit flies have greatly contributed to our understanding of neuroscience. The
use of an unparalleled wealth of tools, many of which originated between 1910–1960, has …

Carcinogenicity and modification of the carcinogenic response by BHA, BHT, and other antioxidants

N Ito, S Fukushima, H Tsuda - CRC Critical reviews in Toxicology, 1985 - Taylor & Francis
V. SUMMARY Carcinogenicity tests showed that addition of the antioxidant BHA to the diet
of F344 rats induced high incidences of papilloma and squamous cell carcinoma of the …

Oral appliance treatment for obstructive sleep apnea: an update

K Sutherland, OM Vanderveken, H Tsuda… - Journal of Clinical …, 2014 - jcsm.aasm.org
Oral appliances (OA) have emerged as an alternative to continuous positive airway pressure
(CPAP) for obstructive sleep apnea (OSA) treatment. The most commonly used OA reduces …

Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement

…, H Tomiyama, K Takeda, H Tsuda… - Hypertension …, 2002 - jstage.jst.go.jp
The present study was conducted to evaluate the validity and reproducibility of noninvasive
brachial-ankle pulse wave velocity (baPWV) measurements and to examine the alteration of …

KIF5B-RET fusions in lung adenocarcinoma

…, I Sekine, S Ogawa, CC Harris, H Tsuda… - Nature medicine, 2012 - nature.com
We identified in-frame fusion transcripts of KIF5B (the kinesin family 5B gene) and the RET
oncogene, which are present in 1–2% of lung adenocarcinomas (LADCs) from people from …

Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model

…, Y Ito, Y Kawano, K Kurozumi, M Kobune, H Tsuda… - Gene therapy, 2004 - nature.com
The prognosis of patients with malignant glioma is extremely poor, despite the extensive
surgical treatment that they receive and recent improvements in adjuvant radio-and …

Antigen–specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs

LL Green, MC Hardy, CE Maynard-Currie, H Tsuda… - Nature …, 1994 - nature.com
We describe a strategy for producing human monoclonal antibodies in mice by introducing
large segments of the human heavy and κ light chain loci contained on yeast artificial …

Studies on antioxidants: their carcinogenic and modifying effects on chemical carcinogenesis

N Ito, M Hirose, S Fukushima, H Tsuda, T Shirai… - Food and Chemical …, 1986 - Elsevier
Studies were conducted on the carcinogenic activity of butylated hydroxyanisole (BHA) in
rats and hamsters. To obtain information concerning the mechanism of action of BHA on the …

Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1: Th2 cell ratio during normal human pregnancy and preeclampsia

…, M Sakai, Y Sasaki, K Tanebe, H Tsuda… - Clinical & …, 1999 - academic.oup.com
We calculated the percentage of Th1, Th2, Th0 cells and the Th1: Th2 cell ratio of peripheral
blood from normal pregnant subjects and preeclampsia patients using flow cytometry which …

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

…, F Takahashi, S Isonishi, T Jobo, D Aoki, H Tsuda… - The Lancet, 2009 - thelancet.com
Background Paclitaxel and carboplatin given every 3 weeks is standard treatment for
advanced ovarian carcinoma. Attempts to improve patient survival by including other drugs …